USMLE Step 1 practice question: Follicular lymphoma t(14;18): BCL-2 blocks intrinsic apoptosis
USMLE Step 1General PrinciplesPathology
The gene product overexpressed as a result of this translocation promotes tumor growth primarily by which of the following mechanisms?
- Blocking caspase-8 activation by death receptors such as Fas
- Overexpressing cyclin D1 to accelerate the G1-to-S phase transition
- Constitutively activating a cytoplasmic tyrosine kinase signaling pathway
- Preventing mitochondrial outer membrane permeabilization by BAX and BAK
- Acting as a transcription factor that drives rapid cell proliferation
Show answer and explanation
Correct answer: D. Preventing mitochondrial outer membrane permeabilization by BAX and BAK
Waxing and waning, painless, generalized lymphadenopathy in an older adult, a nodular (follicular) pattern of small cleaved cells (centrocytes) expressing B-cell (CD20) and germinal center (CD10, BCL6) markers, and t(14;18) indicate follicular lymphoma.
The translocation places the BCL2 gene (18q21) next to the immunoglobulin heavy chain locus (14q32), whose strong enhancer drives constitutive BCL-2 overexpression. BCL-2 is an antiapoptotic member of the protein family that controls the intrinsic (mitochondrial) pathway of apoptosis. It binds and restrains the proapoptotic effectors BAX and BAK, preventing them from forming pores in the outer mitochondrial membrane. As a result, cytochrome c is not released, the apoptosome (cytochrome c, APAF1 and caspase-9) does not assemble, and executioner caspases are not activated. Germinal center B cells that would normally die survive, so the tumor grows by accumulation rather than by rapid proliferation.
This explains the clinical course: follicular lymphoma is usually indolent with a low mitotic rate, but it is generally incurable and may transform into aggressive diffuse large B-cell lymphoma. Unlike reactive germinal centers, which are BCL-2 negative, neoplastic follicles stain strongly for BCL-2. BH3-mimetic drugs such as venetoclax inhibit BCL-2 directly.
Why the other options are wrong
- A. Blocking caspase-8 activation by death receptors such as Fas — The extrinsic pathway is inhibited by proteins such as FLIP that block caspase-8 activation; BCL-2 acts on the intrinsic, mitochondrial pathway.
- B. Overexpressing cyclin D1 to accelerate the G1-to-S phase transition — Cyclin D1 overexpression results from t(11;14) in mantle cell lymphoma, whose cells are CD5 positive and CD10 negative.
- C. Constitutively activating a cytoplasmic tyrosine kinase signaling pathway — Constitutive tyrosine kinase activity is characteristic of BCR-ABL1 from t(9;22) in chronic myeloid leukemia.
- E. Acting as a transcription factor that drives rapid cell proliferation — MYC, a transcription factor activated by t(8;14) in Burkitt lymphoma, drives very rapid proliferation with a starry-sky pattern.
Key point
In follicular lymphoma, t(14;18) causes BCL-2 overexpression, which blocks the intrinsic apoptotic pathway by preventing BAX/BAK-mediated mitochondrial outer membrane permeabilization.
Memory hook
Fourteen-eighteen keeps the mitochondrial door shut: BCL-2 cells forget to die rather than race to divide, so the lymphoma creeps.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free